Avai Bio (AVAI) Payables (2018 - 2026)

Avai Bio has disclosed Payables across 9 years of filings, most recently posting $2.5 million for Q2 2026.

• In Q2 2026, Payables rose 75.72% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $2.5 million (up 75.72% YoY), while the FY2026 annual figure was $2.1 million, up 67.87% from the prior year.
• Payables came in at $2.5 million for Q2 2026 at Avai Bio, up from $2.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $2.5 million in Q2 2026 to a low of $171486.0 in Q1 2022.
• Average Payables over 5 years is $1.1 million, with a median of $1.3 million recorded in 2024.
• Year-over-year, Payables tumbled 64.19% in 2022 and jumped 330.98% in 2024.
• Over 5 years, Payables stood at $303669.0 in 2022, then jumped by 277.22% to $1.1 million in 2023, then soared by 54.46% to $1.8 million in 2024, then gained by 10.18% to $1.9 million in 2025, then gained by 27.54% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $2.5 million in Q2 2026, $2.1 million in Q1 2026, and $1.9 million in Q4 2025.